For this we performed OncoPPi screening to map potential oncogenic GATAD2B interactors using a lung-cancer associated gene library45, and a highly efficient protein-protein interaction (PPI) detection platform derived from BRETn technology46,47. This evidence concerns the gene GATAD2B and lung carcinoma.